a solid-phase radioimmunoassay was utilized to evaluate the antibody response of 21 acute myelogenous leukemia ( aml ) patients to active specific immunotherapy with either pooled allogeneic aml blast cells or leukemia-associated antigen ( laa ) , admixed with bcg cell-wall skeleton ( cws ) .
C0023467
aml
C0023418
associated